Back to ELVN
Blackstone Inc. ELVN Position History
Enliven Therapeutics, Inc. • Healthcare
Quarters held
9
Latest value
$10.9M
Q2 2026
Peak value
$27M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $443K |
| Q2 2024 | $7.5M |
| Q3 2024 | $9.5M |
| Q4 2024 | $8.4M |
| Q1 2025 | $15M |
| Q2 2025 | $26.5M |
| Q3 2025 | $27M |
| Q4 2025 | $14.7M |
| Q2 2026 | $10.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $10.9M | 215.7K | — | — |
| Q4 2025 | $14.7M | 954.9K | — | — |
| Q3 2025 | $27M | 1.32M | — | — |
| Q2 2025 | $26.5M | 1.32M | — | — |
| Q1 2025 | $15M | 762.3K | — | — |
| Q4 2024 | $8.4M | 373.3K | — | — |
| Q3 2024 | $9.5M | 373.3K | — | — |
| Q2 2024 | $7.5M | 321.2K | — | — |
| Q1 2024 | $443K | 25.2K | — | — |
Other funds holding ELVN
$101.9M
$101.9M
$61.7M
$61.6M
$61.6M
$42.8M